Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun 14;37(23):1789-98.
doi: 10.1093/eurheartj/ehw113. Epub 2016 Apr 7.

Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure

Rosalinda Madonna  1 , Linda W Van Laake  2 , Sean M Davidson  3 , Felix B Engel  4 , Derek J Hausenloy  5 , Sandrine Lecour  6 , Jonathan Leor  7 , Cinzia Perrino  8 , Rainer Schulz  9 , Kirsti Ytrehus  10 , Ulf Landmesser  11 , Christine L Mummery  12 , Stefan Janssens  13 , James Willerson  14 , Thomas Eschenhagen  15 , Péter Ferdinandy  16 , Joost P G Sluijter  17
Affiliations
Review

Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure

Rosalinda Madonna et al. Eur Heart J. .

Abstract

Despite improvements in modern cardiovascular therapy, the morbidity and mortality of ischaemic heart disease (IHD) and heart failure (HF) remain significant in Europe and worldwide. Patients with IHD may benefit from therapies that would accelerate natural processes of postnatal collateral vessel formation and/or muscle regeneration. Here, we discuss the use of cells in the context of heart repair, and the most relevant results and current limitations from clinical trials using cell-based therapies to treat IHD and HF. We identify and discuss promising potential new therapeutic strategies that include ex vivo cell-mediated gene therapy, the use of biomaterials and cell-free therapies aimed at increasing the success rates of therapy for IHD and HF. The overall aim of this Position Paper of the ESC Working Group Cellular Biology of the Heart is to provide recommendations on how to improve the therapeutic application of cell-based therapies for cardiac regeneration and repair.

Keywords: Cell-based therapy; Heart Failure; Heart Regeneration; Heart repair; Ischaemic heart disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of experimental design starting from preclinical studies and ending to the human clinical trials.
See this image and copyright information in PMC

References

    1. Baker M. Stem cells by any other name. Nature 2007;449:389. - PubMed
    1. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011;378:1847–1857. - PMC - PubMed
    1. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, Salio M, Battaglia M, Latronico MV, Coletta M, Vivarelli E, Frati L, Cossu G, Giacomello A. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004;95:911–921. - PubMed
    1. Boland MJ, Nazor KL, Loring JF. Epigenetic regulation of pluripotency and differentiation. Circ Res 2014;115:311–324. - PMC - PubMed
    1. Basile DP, Yoder MC. Circulating and tissue resident endothelial progenitor cells. J Cell Physiol 2014;229:10–16. - PMC - PubMed

Publication types